Concomitant psychotropic medication and electroconvulsive therapy on Schizophrenia
Phase 2
- Conditions
- schizophrenia.Schizophrenia
- Registration Number
- IRCT201107143930N7
- Lead Sponsor
- Vice chancellor for research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusive criteria: Diagnosed schizophrenia in accordance with DSM-IV, needs to be applied electroconvulsive therapy (ECT) determined by psychiatrist; providing written informed consent.
Exclusion Criteria
Patient who does not volunteer himself or herself, Serious neurological or medical damage such as epilepsy, diabetes, cardiac disease or autistic disorder.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Positive and Negative Syndrome Scale for schizophrenia (PANSS). Timepoint: before first ECT session and about 4 weeks after the last session of ECT. Method of measurement: Interview.
- Secondary Outcome Measures
Name Time Method A modified version of Mini Mental Status Evaluation. Timepoint: before first ECT session, after every session of ECT, and about 4 weeks after the last session of ECT. Method of measurement: interview.